We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Abuse-Deterrent ADHD Drug Gets Thumbs-Down From Expert Panels
Abuse-Deterrent ADHD Drug Gets Thumbs-Down From Expert Panels
Arbor Pharmaceuticals’ AR19, an abuse-deterrent formulation of amphetamine sulfate for attention deficit hyperactivity disorder (ADHD) should not receive FDA approval, two of the agency’s advisory committees voted unanimously in a joint meeting yesterday.